Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography

Annals of Surgery

Volumn 231, Issue 2, 2000, Pages 229-234

  Stokkel, Marcel P M ^a,b   Ten Broek, Frans Willem ^a   Hordijk, Gerrit Jan ^a   Koole, Ron ^a   Van Rijk, Peter P ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; OROPHARYNX CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 0033980725     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200002000-00012     Document Type: Article

References (29)

1. Parker SL, Tong T, Bolden S, et al. Cancer statistics 1996. CA Cancer J Clin 1996; 46:5-27.
2. Snow GB, Patel P, Leemans CR, Tiwari R. Management of cervical lymph nodes in patients with head and neck cancer. Eur Arch Otorhinolaryngol 1992; 249:187-194.
3. Whitehurst JO, Droulias CA. Surgical treatment of squamous cell carcinoma of the oral tongue. Arch Otolaryngol 1987; 103:212-215.
4. Sham JS, Choy D. Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients. Br J Radiol 1990; 63:51-58.
5. Leemans TR, Tiwari R, van der Waal I, Karim ABMF, Nauta JJP, Snow GB. The efficacy of comprehensive postoperative radiotherapy in nodal metastases of squamous cell carcinoma of the upper respiratory and digestive tract. Laryngoscope 1990; 100:1194-1198.
6. Van den Breekel MWM, Stel HV, Castelijns JA, et al. Cervical lymph node metastasis: assessment of radiologie criteria. Radiology 1990; 177:379-384.
7. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 1953; 6:963-968.
8. Jovanovic A, van der Tol IGH, Kostense PJ, et al. Second respiratory and upper digestive tract cancer following oral squamous cell carcinoma. Eur J Cancer B Oral Oncol 1994; 306:225-229.
9. Schwartz LH, Oszahin M, Zhang GN, et al. Synchronous and metachronous head and neck carcinomas. Cancer 1994; 74:1933-1938.
10. Parker JT, Hill JH. Panendoscopy in screening for synchronous primary malignancies. Laryngoscope 1988; 98:147-149.
11. Hordijk GJ, Bruggink T, Ravasz LA. Panendoscopy: a valuable procedure. Laryngol Head Neck Surg 1989; 101:426-428.
12. Dhooge IJ, de Vos J, Albers FWJ. Panendoscopy as a screening procedure for simultaneous primary tumors in head and neck cancer. Eur Arch Otorhinolaryngol 1996; 253:319-324.
13. McGarry GW, Mackenzie K, Periasamy P, McGurk F, Gatehouse S. Multiple primary malignant tumours in patients with head and neck cancer: the implications for follow-up. Clin Otolaryngol 1992; 17: 558-562.
14. Myers LL, Wax MK, Nabi H, Simpson GT, Lamonica D. Positron emission tomography in the evaluation of the N0 neck. Laryngoscope 1998; 108:232-236.
15. Benchaou M, Lehman W, Slosman DO. et al. The role of FDG PET in the preoperative assessment of N staging in head and neck cancer. Acta Otolaryngol 1996; 116:332-335.
16. 18-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998; 25:1255-1260.
17. 18)-fluoro-2-deoxy-D-glucose and MR imaging cor-relation. Radiology 1993; 186:27-35.
18. Steinkamp HJ, Maurer J, Heim T, Knobber D, Felix R. Magnetresonanz-tomographie und computertomographie im tumorstaging des mundhohlen oropharynxkarzinoms. HNO 1993; 41:519-525.
19. Laubenbacher C, Saumweger D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous cell carcinomas. J Nucl Med 1995; 36:1714-1757.
20. 18)-fluoro-2-deoxy-D-glucose SPECT. Radiology 1996; 199:761-766.
21. Kole AC, Nieweg OE, Pruim J, et al. Detection of unknown occult primary tumors using positron emission tomography. Cancer 1998; 82:1160-1166.
22. 18 FDG in patients with unknown origin tumors. J Nucl Med 1995; 36(suppl):194P.
23. Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and statistical study. Am J Cancer 1932; 51:1358-1403.
24. Dhooge IJ, de Vos M, van Cauwenberge PB. Multiple primary malignant tumors in patients with head and neck cancer: results of a prospective study and future perspectives. Laryngoscope 1988; 108:250-256.
25. Jones AS, Morar P, Phillips DE, Field JK, Husband D, Helliwell TR. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 1995; 75:1343-1353.
26. Gluckman JL, Crissman JD. Survival rates in 548 patients with multiple neoplasms of the upper aerodigestive tract. Laryngoscope 1983; 93:71-74.
27. Larson JT, Adams GL, Fattah HA. Survival statistics for multiple primaries in head and neck cancer. Otolaryngol Head Neck Surg 1990; 103:14-24.
28. Haughey BH, Gates GA, Arfken CL, Harvey J. Metaanalysis of second malignant tumors in head and neck cancer: the case for an endoscopie screening protocol. Ann Otol Rhinol Laryngol 1992; 101:105-112.
29. Braams JW, Pruim J, Freling NJM, et al. Detection of lymph node metastases of squamous cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 1995; 36:211-216. Vertex MCD, ADAC, Milpitas, CA